UPDATE: H.C. Wainwright Starts Context Therapeutics (CNTX) at Buy

February 2, 2022 6:09 AM EST Send to a Friend
(Updated - February 2, 2022 6:39 AM EST)

H.C. Wainwright analyst Emily Bodnar initiates coverage on Context Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login